MicroRNA-26b−/− augments atherosclerosis, while mimic-loaded nanoparticles reduce atherogenesis
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvaf234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Linsey J F Peters und 19 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cardiovascular Prevention (IPEK), LMU Munich, 80336 Munich, Germany. Hauptthemen laut MEDLINE: MicroRNAs, Atherosclerosis, Plaque, Atherosclerotic, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Interdisciplinary Center for Clinical Research, RWTH Aachen University, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Aims
Increasing evidence has shown that microRNAs (miRs) play a fundamental role in atherosclerosis, but the exact role of various miRs remains elusive. Preliminary data showed that, with a five-fold increase, miR-26b was highly expressed in human atherosclerotic plaques compared to healthy vessels. Therefore, we aimed to determine its cell-specific effects on atherosclerosis development and its therapeutic potential. Methods and results We examined the role of miR-26b in atherosclerosis by using whole-body Apoe−/−Mir26b−/− and myeloid cell-specific miR-26b-deficient (LysM-Cre) mice on a Western-type diet (WTD). Atherosclerotic plaque size and phenotype, as well as the phenotype and function of bone marrow-derived macrophages (BMDMs) from Apoe−/−Mir26b−/− mice, were investigated. Lipid nanoparticles (LNPs) served as vehicles for miR-26b mimics to restore miR-26b levels in miR-26b-deficient BMDMs in vitro and in mice in vivo. Apoe−/−Mir26b−/− mice have a striking 2.8-fold increase in atherosclerotic lesion size in the aortic arch after 12-week WTD, compared to control Apoe−/−, while lesions in the aortic root were unaffected. Consistent with a more advanced plaque phenotype, collagen, smooth muscle cell, and necrotic core content were all significantly increased in plaques from Apoe−/−Mir26b−/− mice, whilst the relative macrophage content was significantly reduced. This phenotype could also be observed in Apoe−/−Mir26b−/− mice after 4-week WTD. Intriguingly, relative plaque size in the arches of Apoe−/−LysmCre+Mir26bfl/fl mice was increased by 2.5-fold, suggesting a role for myeloid-specific miR-26b in atherosclerosis development. Further highlighting its myeloid-specific effects, Apoe−/−Mir26b−/− BMDMs showed an increase in pro-inflammatory cytokine secretion, which could be rescued by LNPs containing miR-26b mimics. MiR-26b pull-down analysis revealed AnnexinA2 as one of the novel targets playing a key role in these effects, which could be validated in BMDMs in vitro. Furthermore, in vivo treatment of Apoe−/−Mir26b−/− mice as well as ex vivo treatment of human plaques with miR-26b-mimic-loaded LNPs demonstrated their therapeutic potential and human relevance, respectively.
Conclusion
Overall, our results clearly demonstrate an atheroprotective role of miR-26b by attenuating lesion formation, mainly by suppressing inflammation and stimulating collagen breakdown. Furthermore, the therapeutic potential of miR-26b mimic-loaded LNPs could be proven, opening up new avenues for miRNA-based treatment options in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Cardiovascular Prevention (IPEK), LMU Munich, 80336 Munich, Germany.
- Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, 52074 Aachen, Germany.
- Aachen-Maastricht Institute for CardioRenal Disease (AMICARE), RWTH Aachen University, Pauwelsstrasse 17, Aachen 52074, Germany.
- Department of Medicine III, University Hospital Aachen, Aachen 52074, Germany.
- Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht 6229 ER, The Netherlands.
- Department for Renal and Hypertensive, Rheumatological and Immunological Diseases (Medical Clinic II), RWTH Aachen, 52074 Aachen, Germany.
ORCID-Profile: Judith C Sluimer, Marion J Gijbels, Joachim Jankowski, Yvonne Döring, Emiel P C van der Vorst
Förderung
- Interdisciplinary Center for Clinical Research
- RWTH Aachen University
- Deutsche Forschungsgemeinschaft
- Corona Foundation
- Chinese Scholarship council
- Netherlands organization for scientific research
Zitieren
APA
Peters, L. J. F., Bidzhekov, K., Bonnin-Marquez, A., Sundararaman, S. S., Huchzermeier, R., Maas, S. L., Abschlag, K., Jans, A., Lin, C., Haberbosch, M., Jansen, Y., Yu, B., Sluimer, J. C., Gijbels, M. J., Jankowski, J., Bartneck, M., Biessen, E. A. L., Weber, C., Döring, Y., & van der Vorst, E. P. C. (2025). MicroRNA-26b−/− augments atherosclerosis, while mimic-loaded nanoparticles reduce atherogenesis. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf234
Vancouver
Peters LJF, Bidzhekov K, Bonnin-Marquez A, Sundararaman SS, Huchzermeier R, Maas SL, et al. MicroRNA-26b−/− augments atherosclerosis, while mimic-loaded nanoparticles reduce atherogenesis. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf234
BibTeX
@article{Peters2025,
author = {Peters, Linsey J F and Bidzhekov, Kiril and Bonnin-Marquez, Andrea and Sundararaman, Sai Sahana and Huchzermeier, Rosanna and Maas, Sanne L and Abschlag, Kathrin and Jans, Alexander and Lin, Cheng and Haberbosch, Markus and Jansen, Yvonne and Yu, Baixue and Sluimer, Judith C and Gijbels, Marion J and Jankowski, Joachim and Bartneck, Matthias and Biessen, Erik A L and Weber, Christian and Döring, Yvonne and van der Vorst, Emiel P C},
title = {MicroRNA-26b−/− augments atherosclerosis, while mimic-loaded nanoparticles reduce atherogenesis},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvaf234}
}
EUVIMED